• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

兰索拉唑和奥美拉唑对幽门螺杆菌的体外杀菌活性。

Bactericidal activity of lansoprazole and omeprazole against Helicobacter pylori in vitro.

作者信息

Vogt K, Hahn H

机构信息

Department of Microbiology, Hospital Virchow and Charité, Humboldt University of Berlin, Germany.

出版信息

Arzneimittelforschung. 1998 Jun;48(6):694-7.

PMID:9689430
Abstract

The minimum inhibitory concentrations of 39 Helicobacter pylori strains against antibiotics (ampicillin, tetracycline, metronidazole), colloidal bismuth subcitrate and proton pump inhibitors were assessed by the agar dilution method. 20.5% of the strains were metronidazole resistent. The comparison of the bactericidal action of omeprazole and lansoprazole in a killing curve assay showed a dose-dependent reduction of viable bacteria after 24 h, lansoprazole being more effective than omeprazole. Under varying pH conditions, the antibacterial activity of lansoprazole was limited to a pH range of 6-7, reducing bacterial numbers up to 4 logarithmical steps within 24 h.

摘要

采用琼脂稀释法评估了39株幽门螺杆菌对抗生素(氨苄青霉素、四环素、甲硝唑)、枸橼酸铋钾和质子泵抑制剂的最低抑菌浓度。20.5%的菌株对甲硝唑耐药。在杀菌曲线试验中比较奥美拉唑和兰索拉唑的杀菌作用,结果显示24小时后活菌数量呈剂量依赖性减少,兰索拉唑比奥美拉唑更有效。在不同pH条件下,兰索拉唑的抗菌活性局限于pH 6 - 7范围,24小时内可使细菌数量减少多达4个对数级。

相似文献

1
Bactericidal activity of lansoprazole and omeprazole against Helicobacter pylori in vitro.兰索拉唑和奥美拉唑对幽门螺杆菌的体外杀菌活性。
Arzneimittelforschung. 1998 Jun;48(6):694-7.
2
The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.甲硝唑耐药水平对幽门螺杆菌根除成功的重要性。
Aliment Pharmacol Ther. 2004 Jun 15;19(12):1315-21. doi: 10.1111/j.1365-2036.2004.01959.x.
3
Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.兰索拉唑单独及与抗菌药物联合对幽门螺杆菌的抗菌特性。
Eur J Clin Microbiol Infect Dis. 1995 May;14(5):391-9. doi: 10.1007/BF02114894.
4
Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.幽门螺杆菌根除对胃食管反流病患者兰索拉唑抗分泌疗效的影响。
J Gastroenterol Hepatol. 2005 Dec;20(12):1886-91. doi: 10.1111/j.1440-1746.2005.03896.x.
5
In vitro activity of ebrotidine, ranitidine, omeprazole, lansoprazole, and bismuth citrate against clinical isolates of Helicobacter pylori.依罗替丁、雷尼替丁、奥美拉唑、兰索拉唑和枸橼酸铋对幽门螺杆菌临床分离株的体外活性
Eur J Clin Microbiol Infect Dis. 1998 Apr;17(4):275-7. doi: 10.1007/BF01699986.
6
Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.大环内酯类药物与质子泵抑制剂对幽门螺杆菌的协同相互作用:一项体外比较研究。
J Antimicrob Chemother. 1998 Mar;41 Suppl B:29-35. doi: 10.1093/jac/41.suppl_2.29.
7
Inhibitory activities of lansoprazole against respiration in Helicobacter pylori.兰索拉唑对幽门螺杆菌呼吸作用的抑制活性。
Antimicrob Agents Chemother. 2001 May;45(5):1522-7. doi: 10.1128/AAC.45.5.1522-1527.2001.
8
Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.兰索拉唑单独及与抗菌药物联合对幽门螺杆菌的抗菌特性。
J Clin Gastroenterol. 1995;20 Suppl 1:S32-7. doi: 10.1097/00004836-199506001-00008.
9
Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.兰索拉唑是一种新型苯并咪唑质子泵抑制剂,其相关化合物对幽门螺杆菌具有选择性活性。
Antimicrob Agents Chemother. 1991 Mar;35(3):490-6. doi: 10.1128/AAC.35.3.490.
10
[Activity of Lansoprazole (new proton pump inhibitor) against Helicobacter pylori and its therapeutic efficacy].
Nihon Rinsho. 1993 Dec;51(12):3261-6.

引用本文的文献

1
Lansoprazole: an update of its place in the management of acid-related disorders.兰索拉唑:其在酸相关性疾病管理中地位的最新进展
Drugs. 2001;61(12):1801-33. doi: 10.2165/00003495-200161120-00011.